Taking Dagliflozin to urinate a dozen times a day may be normal. Dagliflozin is a new type of hypoglycemic drug used to improve glycemic control in adult patients with type 2 diabetes. The mechanism of Dagliflozin is to inhibit the reabsorption of glucose in the renal tubules and increase urine sugar to achieve the purpose of lowering sugar. It is normal for some people to have excessive urination. Dagliflozin has some cardioprotective and renoprotective effects, but dagliflozin increases the risk of genital fungal infections, and patients with a history of genital fungal infections are more susceptible to genital fungal infections, so they should be monitored and treated accordingly. In addition, dagliflozin treatment can increase the risk of urinary tract infections. Dagliflozin is contraindicated in patients with severe renal impairment, end-stage renal disease, or those requiring dialysis. Taking Dagliflozin to urinate more than ten times a day may be normal. It is recommended that patients who encounter unresolved phenomenon after taking Dagliflozin should consult a doctor for professional guidance.